ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Heckler Announces NCI Team Headed By Gallo Has Found Cause Of AIDS

April 27, 1984

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977

Amgen, J&J Defend ESA Indications.

March 21, 2008

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992

In Brief: Gramm-Rudman-Hollings Could Slash NCI Budget By $650 Million; Holleb Retires From ‘Ca’

July 27, 1990

Preliminary Report Tends To Support Pill’s Association With Liver Tumors

November 19, 1976